News

ProVen Growth and Income VCT plc Expands Share Capital Significantly

ProVen Growth and Income VCT plc Expands Share Capital Significantly

ProVen Growth and Income VCT plc Strengthens Its Position

ProVen Growth and Income VCT plc, often referred to simply as the Company, recently marked a significant milestone in its journey by announcing a new allotment of ordinary shares. This strategic move is part of their ongoing efforts to enhance their equity offerings and support future growth initiatives.

Details of the Share Allotment

On a noteworthy date, the Directors of ProVen Growth and Income VCT plc officially declared the allotment of 6,491,615 ordinary shares at a price of 52.78p per share. This determination follows the subscription offer that commenced just a few months prior, on 6 November 2024. This initiative reflects a confident step towards strengthening the company's financial base.

Financial Insights

The shares were allotted based on the latest net asset value of 50.45p per share as of 30 November 2024, taking into account a dividend payout of 1.25p made on 17 January 2025. This careful financial management showcases the Company’s commitment to maximizing value for its shareholders.

Next Steps for the Company

As part of the regulatory process, ProVen Growth and Income VCT plc will be submitting an application for these newly issued shares to be listed on the Official List of the Financial Conduct Authority. Additionally, trading on the London Stock Exchange's market for listed securities will follow. This development marks a vital step towards integrating the new shares into the broader market.

Shareholder Relations and Future Prospects

Importantly, the newly allotted shares are positioned to rank pari passu with the existing ordinary shares. This means that they will hold equal status and rights amongst current shareholders, reinforcing fairness and transparency in share ownership. With an updated total of 318,914,605 ordinary shares, the Company is poised to enhance its visibility and attractiveness in the financial realm.

Company Communication

For stakeholders seeking insights or clarification regarding these developments, the Company Secretary, Beringea LLP, remains a vital point of contact. Interested parties can utilize the following telephone number for inquiries: 020 7845 7820. It is through such consistent communication that ProVen Growth and Income VCT plc aims to maintain robust relations with its shareholders.

Frequently Asked Questions

What is the recent share allotment by ProVen Growth and Income VCT plc?

The Company announced an allotment of 6,491,615 ordinary shares at 52.78p each as part of their equity offerings.

How does the share allotment impact existing shareholders?

The newly issued shares will rank pari passu with the existing shares, meaning all shareholders have equal rights.

What is the purpose of this allotment?

This move aims to strengthen the Company's financial base and support future growth initiatives.

Who can I contact for more information about this development?

Shareholders can reach out to Beringea LLP, the Company Secretary, at 020 7845 7820 for any inquiries.

Where will the new shares be traded?

Application will be made for the shares to be listed on the Official List and traded on the London Stock Exchange.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 7

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
HTX's Strategic Moves in Pakistan: A Crypto Frontier

Updated Category News Views 4

Paving the Way: HTX's Journey in Pakistan Rolling into the Pakistan cryptocurrency scene isn't just a 'walk in the park' for HTX—it's more like traversing a new frontier with an open map. This isn’t some hit-and-run operation; HTX is strategizing for a long haul in one of the liveliest digital market arenas in South Asia. Gathering steam with community AMAs and an X...

Continue Reading
Machine Grabs Prime Dallas Property Amid Apartment Boom

Updated Category News Views 1

Dallas' Hot Market and Machine's Bold Move Well, well, looks like Machine Investment Group's been busy flexing its real estate muscles, bagging a 490-unit gem in North Dallas—your typical, no-frills off-market grab. We’re talking 75 West, nestled in a juicy infill spot, and it’s catching eyes like gold dust in a pan. You don't need me to tell you North Dallas ain't...

Continue Reading
AI-Driven Lumi Transforms Car Dealership Interactions

Updated Category News Views 6

Lumi: Changing the Car Buying Game Picture this: You're browsing for a new car, head filled with specifics like towing capacity, price points, and trim options. Usually, such queries would send you bouncing around the web, but Lectrium's Lumi promises to keep the questioning—and decision-making—right on the dealership's page. In a move set to shake up the game,...

Continue Reading
Dr. Desi Bartlett Teams Up with Glo for Perimenopause Focus

Updated Category News Views 3

Glo Taps Top Wellness Expert for Women's Health Initiative In an industry brimming with wellness voices, it's rare to find one that marries scholarly acumen with authentic, personal teaching. Yet, this is precisely what Dr. Desi Bartlett brings to the table as she partners with Glo to offer new fitness programming specifically targeting women facing perimenopause and...

Continue Reading
Davos Healthcare Aims to Revolutionize Hospital Ratings

Updated Category News Views 2

Throw away those dusty, old reputation surveys—Davos Healthcare just turned the spotlight onto cold, hard data with its new global hospital evaluation platform. Why Davos Healthcare’s Initiative Matters At the C3 US NYC Davos of Healthcare™ Summit, an event that’s rooted itself alongside the United Nations General Assembly, Davos Healthcare unveiled a...

Continue Reading
FJBio Boosts Antibody Discovery with Sapio AI

Updated Category News Views 2

In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...

Continue Reading
The Chemical Industry and EPA: A Broken System?

Updated Category News Views 3

Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 6

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading

Top 5 Most Recently Viewed Articles

Stavvy Enhances Digital Mortgage Closing with New Tools

Updated Category News Views 95

Stavvy's Latest Encompass Integration Revolutionizes Mortgage Technology Stavvy has introduced an exciting new integration with Encompass that aims to transform the landscape of digital mortgage processing. This revolutionary development leverages the Encompass Partner Connect API framework from Intercontinental Exchange (ICE), enhancing collaboration within the lending...

Continue Reading
EG 427's Innovations in Neurology Using Advanced Vector Technology

Updated Category News Views 230

Leading the Future of Neurology with Innovative Technology EG 427 has made significant strides in the field of neurology, specifically by developing its innovative non-replicative HSV-1 (nrHSV-1) vector technology. This advanced platform showcases the company's commitment to addressing challenges in genetic medicine, particularly for prevalent neurological pathologies....

Continue Reading
Which Wich® Marks 21 Years with Exciting Promotions and Deals

Updated Category News Views 220

Celebrating 21 Years of Which Wich® Superior Sandwiches Which Wich® Superior Sandwiches is thrilled to celebrate its 21st anniversary with exciting promotions and community initiatives leading up to the end of the year. Guests are invited to partake in scratch-off prizes, a special Thanksgiving giveback, and a newly introduced "Bag of the Day" promotion. These are...

Continue Reading
Elon Musk's Bold Statements on Immigration Policies Revealed

Updated Category News Views 279

Elon Musk's Critique of Immigration Policies Elon Musk has recently expressed his deep concerns regarding immigration policies, asserting they are being used to undermine the foundations of democracy. Musk took to X to share his thoughts, claiming that 'fraudulent government programs' are being leveraged by political factions to manipulate the immigration system....

Continue Reading
Revolutionary Workout Bar Designed for Home Fitness Efficiency

Updated Category News Views 133

Innovative Home Workout Solution Creating innovative solutions for fitness enthusiasts is a continuous journey. An inventor recently introduced a remarkable accessory designed to make exercising at home more efficient. The COUNTER ATTACK aims to assist individuals in carrying out various exercises quickly and effectively without needing traditional gym equipment....

Continue Reading